Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a deployment of the front-end platform; this appears to be an internal update rather than a change to study details or eligibility information.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page. This indicates a minor site update without changes to the study content.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing the previous Revision: v3.6.2. This reflects a version update to the page's metadata.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision v3.6.2 was added. The previous revision v3.6.0 was removed.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now indicates no longer looking for participants and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label formatting is adjusted and the site revision is updated to v3.6.0.SummaryDifference0.5%

- Check85 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. No direct content changes to the study page are shown.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.